Weekly Digest – May 2024 Weekly Digest – May 2024 21 May 2024: Enhertu receives expanded indication for breast and lung cancer Daiichi Sankyo Korea and AstraZeneca Korea announced MFDS approval of Enhertu (trastuzumab deruxtecan) for HER2-low metastatic breast cancer […]
Contact:
info@ciscientists.com
+1-908-212-7484
Optimal Dose
For a subscription, please provide your email id